All research
Tirzepatide 2026-06-01 PubMed

Massive Type IV Hiatal Hernia with Gastric Volvulus Complicates Recovery Following Tirzepatide Dose Increase

A Massive Type IV Hiatal Hernia With Gastric Volvulus and the Complicated Road to Recovery.

Background

Massive Type IV paraesophageal hiatal hernias are rare but pose a significant risk of life-threatening complications, including gastric volvulus, incarceration, and herniation of other intra-abdominal organs. Pancreatic herniation and associated pancreatitis are exceptionally uncommon. Current surgical approaches aim for reduction and repair, but recurrence and long-term complications remain substantial challenges, particularly in patients with comorbidities or multi-organ involvement. Understanding potential triggers or exacerbating factors for these complex presentations is crucial for patient management and risk assessment.

Study Design

This case report details a 74-year-old woman with Barrett's esophagus, COPD, and obesity who presented with nausea, vomiting, and abdominal pain following a recent increase in her tirzepatide dose. Imaging confirmed a massive Type IV paraesophageal hernia with organoaxial gastric volvulus. Initial laparoscopic reduction was aborted due to dense adhesions and a foreshortened esophagus. She subsequently developed progressive herniation involving the stomach, colon, and pancreatic body and tail, necessitating delayed robotic-assisted repair. The patient's complex postoperative course was monitored for recurrences and complications.

Results

The patient's initial laparoscopic repair was unsuccessful due to significant anatomical challenges. Following this, she experienced progressive herniation, ultimately requiring a delayed robotic-assisted repair. Despite this advanced surgical approach, her postoperative course was highly complicated by multiple recurrences, including episodes of volvulus, duodenal obstruction, and mild pancreatitis. She subsequently required an open repair with mesh reinforcement and gastropexy after unsuccessful endoscopic detorsion. This intervention provided temporary improvement, but she later developed recurrent herniation and severe gastroparesis, which was likely secondary to injury to the vagal nerve during the extensive surgical interventions. The case highlights the persistent challenges in achieving definitive repair and preventing long-term sequelae. > The patient experienced multiple recurrences of gastric volvulus and herniation, ultimately developing severe gastroparesis likely due to vagal nerve injury, despite advanced surgical repairs.

Key Findings

  • A 74-year-old woman developed a massive Type IV hiatal hernia with organoaxial gastric volvulus.
  • The hernia presentation followed a recent increase in her tirzepatide dose.
  • Initial laparoscopic repair was aborted due to dense adhesions and a foreshortened esophagus.
  • Patient required delayed robotic-assisted repair, followed by open repair with mesh reinforcement and gastropexy.
  • Postoperative course was complicated by multiple recurrences, volvulus, duodenal obstruction, pancreatitis, and severe gastroparesis.

Why It Matters

This case underscores the extreme complexity and high recurrence rate associated with massive Type IV hiatal hernias, particularly when compounded by multi-organ involvement and patient comorbidities. For clinicians and peptide users, this report highlights the importance of considering gastrointestinal symptoms in patients on tirzepatide, especially after dose escalation, as altered GI motility could potentially exacerbate or precipitate conditions like hiatal hernia complications. While a direct causal link between tirzepatide and the hernia's onset cannot be established from a single case, it suggests a need for heightened vigilance regarding GI health in susceptible individuals. Patients with pre-existing GI conditions, such as hiatal hernias, may require closer monitoring when initiating or escalating GLP-1/GIP agonists. This case also emphasizes that even with advanced surgical techniques, long-term complications and recurrence remain significant challenges in managing these complex conditions.


tirzepatide hiatal-hernia gastric-volvulus case-report gastrointestinal surgical-complications
Source: pubmed:42220762 · Ingested 2026-06-01 · Digest: gemini-2.5-flash